Published in Neurology on May 28, 2013
Spontaneous regression and complete disappearance of the vein of Galen aneurysmal malformation. Childs Nerv Syst (2016) 0.75
Vein of Galen malformation. Neurosurg Focus (2009) 1.28
Vein of Galen aneurysmal malformation in an adult: a case report. Surg Neurol (1996) 1.09
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90
Central nervous system injury associated with cardiac surgery. Lancet (2006) 2.27
Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery. Stroke (2013) 2.05
Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med (2007) 1.89
Novel diagnostic test for acute stroke. Stroke (2003) 1.82
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response. J Biol Chem (2003) 1.80
APOE polymorphism is associated with risk of severe sepsis in surgical patients. Crit Care Med (2005) 1.70
Cognitive function after major noncardiac surgery, apolipoprotein E4 genotype, and biomarkers of brain injury. Anesthesiology (2010) 1.68
Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med (2014) 1.60
Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke (2002) 1.57
Association of neurocognitive function and quality of life 1 year after coronary artery bypass graft (CABG) surgery. Psychosom Med (2006) 1.51
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke (2005) 1.44
Mouse model of subarachnoid hemorrhage associated cerebral vasospasm: methodological analysis. Neurol Res (2002) 1.43
Challenges in enrollment of minority, pediatric, and geriatric patients in emergency and acute care clinical research. Ann Emerg Med (2008) 1.42
Early biomarkers of stroke. Clin Chem (2003) 1.41
A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol (2005) 1.34
Preclinical models of intracerebral hemorrhage: a translational perspective. Neurocrit Care (2008) 1.29
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol (2007) 1.26
Apolipoprotein E-derived peptides ameliorate clinical disability and inflammatory infiltrates into the spinal cord in a murine model of multiple sclerosis. J Pharmacol Exp Ther (2006) 1.14
A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care (2006) 1.09
Pharmacogenomic effects of apolipoprotein e on intracerebral hemorrhage. Stroke (2008) 1.07
Apolipoprotein E isoform mediated regulation of nitric oxide release. Free Radic Biol Med (2002) 1.06
The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg (2002) 1.05
Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg (2003) 1.05
Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol (2002) 1.05
Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke (2009) 1.02
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery (2002) 1.02
Tumor necrosis factor α antagonism improves neurological recovery in murine intracerebral hemorrhage. J Neuroinflammation (2013) 1.01
S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage. Biomarkers (2009) 1.00
Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery (2004) 1.00
Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans. J Stroke Cerebrovasc Dis (2009) 0.99
Correlation of leukocytosis with early neurological deterioration following supratentorial intracerebral hemorrhage. J Clin Neurosci (2012) 0.99
Dissociation between vasospasm and functional improvement in a murine model of subarachnoid hemorrhage. Neurosurg Focus (2006) 0.98
Depression and antidepressant use after stroke and transient ischemic attack. Stroke (2012) 0.97
Transformative Impact of Proteomics on Cardiovascular Health and Disease: A Scientific Statement From the American Heart Association. Circulation (2015) 0.96
Risk of cerebral vasopasm after subarachnoid hemorrhage reduced by statin therapy: A multivariate analysis of an institutional experience. J Neurosurg (2006) 0.95
Long-term cognitive dysfunction following experimental subarachnoid hemorrhage: new perspectives. Exp Neurol (2008) 0.94
Brain natriuretic peptide improves long-term functional recovery after acute CNS injury in mice. J Neurotrauma (2010) 0.93
Predictors of late neurological deterioration after spontaneous intracerebral hemorrhage. Neurocrit Care (2013) 0.93
Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care (2006) 0.92
Evolving role of biomarkers in acute cerebrovascular disease. Ann Neurol (2012) 0.90
Apolipoprotein E expression and behavioral toxicity of high charge, high energy (HZE) particle radiation. J Radiat Res (2002) 0.90
Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury. Neurosci Lett (2005) 0.90
Statins improve outcome in murine models of intracranial hemorrhage and traumatic brain injury: a translational approach. J Neurotrauma (2012) 0.89
Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89
Real-time 3-D contrast-enhanced transcranial ultrasound and aberration correction. Ultrasound Med Biol (2008) 0.88
Clinical application of blood biomarkers in cerebrovascular disease. Expert Rev Neurother (2010) 0.87
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology (2010) 0.86
Gender and age interact to affect early outcome after intracerebral hemorrhage. PLoS One (2013) 0.86
Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity. J Biol Chem (2012) 0.86
Attenuation of cerebral vasospasm after subarachnoid hemorrhage in mice overexpressing extracellular superoxide dismutase. Stroke (2002) 0.86
Apolipoprotein E protects against NMDA excitotoxicity. Neurobiol Dis (2002) 0.85
TT-301 inhibits microglial activation and improves outcome after central nervous system injury in adult mice. Anesthesiology (2012) 0.85
Apolipoprotein E4 increases aortic atheroma burden in cardiac surgical patients. J Thorac Cardiovasc Surg (2003) 0.84
The ultrasound brain helmet: feasibility study of multiple simultaneous 3D scans of cerebral vasculature. Ultrasound Med Biol (2008) 0.84
ApolipoproteinE mimetic peptides improve outcome after focal ischemia. Exp Neurol (2012) 0.83
Effects of a manganese (III) porphyrin catalytic antioxidant in a mouse closed head injury model. Eur J Pharmacol (2006) 0.83
The ultrasound brain helmet: new transducers and volume registration for in vivo simultaneous multi-transducer 3-D transcranial imaging. IEEE Trans Ultrason Ferroelectr Freq Control (2011) 0.83
Interaction between sex and apolipoprotein e genetic background in a murine model of intracerebral hemorrhage. Transl Stroke Res (2012) 0.82
Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2005) 0.82
Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway. Neurol Res (2007) 0.81
Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol (2009) 0.80
Lacosamide improves outcome in a murine model of traumatic brain injury. Neurocrit Care (2013) 0.80
pH-sensitive NMDA inhibitors improve outcome in a murine model of SAH. Neurocrit Care (2014) 0.80
Differential cerebral gene expression during cardiopulmonary bypass in the rat: evidence for apoptosis? Anesth Analg (2002) 0.79
Discriminative capacity of biomarkers for acute stroke in the emergency department. J Emerg Med (2010) 0.79
Biomarkers in traumatic brain injury. Curr Neurol Neurosci Rep (2012) 0.78
Simultaneous bilateral real-time 3-d transcranial ultrasound imaging at 1 MHz through poor acoustic windows. Ultrasound Med Biol (2013) 0.78
Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke (2003) 0.78
Neighborhood socioeconomic status and the prevalence of stroke and coronary heart disease in rural China: a population-based study. Int J Stroke (2014) 0.77
A reversible aptamer improves outcome and safety in murine models of stroke and hemorrhage. Oligonucleotides (2010) 0.76
Management of post-subarachnoid hemorrhage vasospasm. Curr Atheroscler Rep (2008) 0.76
Statins in acute brain injury: getting the cart before the horse. Neurocrit Care (2008) 0.75
Letter by El Husseini et al regarding article, "What causes disability after transient ischemic attack and minor stroke?". Stroke (2012) 0.75
Changing outcome from aneurysmal subarachnoid hemorrhage: another step closer. Anesthesiology (2006) 0.75
Apolipoprotein epsilon 4 genotype is associated with less improvement in cognitive function five years after cardiac surgery: a retrospective cohort study. Can J Anaesth (2015) 0.75
Defining optimal cerebral perfusion pressures in acute brain injury: a step toward individualization of care? Crit Care Med (2010) 0.75
3-D transcranial ultrasound imaging with bilateral phase aberration correction of multiple isoplanatic patches: a pilot human study with microbubble contrast enhancement. Ultrasound Med Biol (2013) 0.75
Response to letter regarding article, "Intraoperative magnesium administration does not improve neurocognitive function after cardiac surgery". Stroke (2014) 0.75
Can D-dimer levels identify patients at risk for early neurological deterioration in acute ischemic stroke? Nat Clin Pract Neurol (2006) 0.75
Biomarkers in stroke: when will they impact care? J Am Coll Cardiol (2010) 0.75
The use of S100B as a biomarker in subarachnoid hemorrhage: clarity in its promise and limits. Crit Care Med (2008) 0.75
The role of neuroendocrine pathways in prognosis after stroke. Expert Rev Neurother (2014) 0.75
813 Intracerebral Infusion of Human Recombinant Apolipoprotein E3 Reduces Global Ischemic Brain Injury in Apolipoprotein E Deficient Mice. Neurosurgery (2000) 0.75
813 Intracerebral Infusion of Human Recombinant Apolipoprotein E3 Reduces Global Ischemic Brain Injury in Apolipoprotein E Deficient Mice. Neurosurgery (2000) 0.75
Erratum: Neuroprotective pentapeptide CN-105 improves functional and histological outcomes in a murine model of intracerebral hemorrhage. Sci Rep (2017) 0.75
Progressive multifocal leukoencephalopathy with occult Waldenström macroglobulinemia. J Clin Oncol (2010) 0.75
871 Simvastatin Reduces Vasospasm after Aneurysmal Subarachnoid Hemorrhage: Results of a Pilot Randomized Clinical Trial. Neurosurgery (2005) 0.75
Use of emergency department transcranial Doppler assessment of reperfusion after intravenous tPA for ischemic stroke. J Emerg Med (2008) 0.75
Synthes Award for Resident Research in Spinal Cord & Spinal Column Injury: Statins for the treatment of neurological injury: a role beyond cholesterol lowering. Clin Neurosurg (2004) 0.75